BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37389564)

  • 21. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study.
    van Reeven M; van Leeuwen OB; van der Helm D; Darwish Murad S; van den Berg AP; van Hoek B; Alwayn IPJ; Polak WG; Porte RJ
    Transpl Int; 2020 Jun; 33(6):667-674. PubMed ID: 32065433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of liver grafts in liver retransplantation: a European single-center experience.
    Martí J; Charco R; Ferrer J; Calatayud D; Rimola A; Navasa M; Fondevila C; Fuster J; García-Valdecasas JC
    Surgery; 2008 Nov; 144(5):762-9. PubMed ID: 19081018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center.
    Hong JC; Kaldas FM; Kositamongkol P; Petrowsky H; Farmer DG; Markovic D; Hiatt JR; Busuttil RW
    Ann Surg; 2011 Sep; 254(3):444-8; discussion 448-9. PubMed ID: 21817890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
    Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of Liver Retransplantation After Rescue Hepatectomy: A Single-Center Study.
    Laine E; Al Sabeah H; Tranäng M; Romano A; Nowak G
    Ann Transplant; 2023 Jun; 28():e939557. PubMed ID: 37277981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of MELD-based allocation on end-stage renal disease after liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Goodrich NP; Ojo AO; Merion RM
    Am J Transplant; 2011 Nov; 11(11):2372-8. PubMed ID: 21883908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of liver transplant recipients with high MELD scores: an experience from a Canadian centre.
    Bleszynski MS; Punnen S; Desai S; Hussaini T; Marquez V; Yoshida EM; Jayakumar S; Chartier-Plante S; Segedi M; Scudamore CH; Chung S; Buczkowski AK; Kim PTW
    Can J Surg; 2022; 65(4):E425-E439. PubMed ID: 35790241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
    Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
    J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.
    Grąt M; Wronka KM; Patkowski W; Stypułkowski J; Grąt K; Krasnodębski M; Masior Ł; Lewandowski Z; Krawczyk M
    Dig Dis Sci; 2016 Feb; 61(2):626-35. PubMed ID: 26499986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil.
    Batista TP; Sabat BD; Melo PS; Miranda LE; Fonseca-Neto OC; Amorim AG; Lacerda CM
    Clinics (Sao Paulo); 2011; 66(1):57-64. PubMed ID: 21437437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France.
    Azoulay D; Disabato M; Gomez-Gavara C; Feray C; Salloum C; Ngonggang N; Winter A; Hentati H; Levesque E; Lim C; Compagnon P
    World J Surg; 2020 Mar; 44(3):912-924. PubMed ID: 31832704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the survival of cirrhotic patients enlisted for liver transplantation in the pre- and post-MELD era in southern Brazil.
    Mattos ÂZ; Mattos AA; Sacco FK; Hoppe L; Oliveira DM
    Arq Gastroenterol; 2014; 51(1):46-52. PubMed ID: 24760064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.